Korsana Biosciences (KRSA) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
12 Oct, 2026Executive summary
Q3 2024 revenue was $194K from an olinciguat option agreement; continuing-operations net loss narrowed to $723K from $5.9M YoY, largely as operating expenses declined. ocument-source4ocument-source5ocument-source9ocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument-sourceocument�����
Latest events from Korsana Biosciences
- KRSA-028 targets monthly subQ dosing, with first patient proof-of-concept due by Q1 2028.KRSA
Stifel 2026 Healthcare Conference 2026 - KRSA-028 aims to pair brain-shuttled plaque clearance with monthly subcutaneous dosing.KRSA
3rd Annual Guggenheim Healthcare Innovation Conference - $456.2M cash supports runway into 2029 as KRSA-028 advances toward clinical testing.KRSA
Q3 2026 - Cayman redomestication would preserve operations while reshaping governance and shareholder rights.KRSA
Proxy filing - CYC-126 advances toward Phase 2, but funding is needed beyond mid-2026.KRSA
Q4 2025 - Board seeks annual say-on-pay votes; March 2025 private placement raised $1.375 million.KRSA
Proxy filing - A $25M shelf backs a CNS-focused portfolio shift amid substantial financing risk.KRSA
Registration filing - A potential TRD pipeline anchors strategy as resale shares bring no proceeds and going-concern risks persist.KRSA
Registration filing - TRD pipeline pivot faces an urgent funding need and substantial going-concern doubt.KRSA
Q4 2024